title: Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity Reaction.
authors.forename: S
authors.initials: S
authors.lastname: Demir
authors.forename: M
authors.initials: M
authors.lastname: Olgac
authors.forename: S
authors.initials: S
authors.lastname: Saglam
authors.forename: A
authors.initials: A
authors.lastname: Gelincik
authors.forename: B
authors.initials: B
authors.lastname: Colakoglu
authors.forename: S
authors.initials: S
authors.lastname: Buyukozturk
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D000069287:Capecitabine / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003888:Desensitization, Immunologic / Q000379:methods*; D004334:Drug Administration Schedule; D003875:Drug Eruptions / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D007108:Immune Tolerance; D007428:Intradermal Tests; D008297:Male; D012867:Skin / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D000069287:Capecitabine